Implementation of Poliovirus Containment in Poliovirus Designated Facilities-United States, 2017-2024. [PDF]
Ottendorfer C +8 more
europepmc +1 more source
Investigation and response to a type 3 vaccine-derived poliovirus detected in an infant with hand, foot, and mouth disease - Guangdong, China, 2023. [PDF]
Li J +8 more
europepmc +1 more source
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial. [PDF]
Hu J +10 more
europepmc +1 more source
Tracking poliovirus through wastewater: environmental surveillance insights from Haïti (2020-2023). [PDF]
Belgasmi-Allen H +11 more
europepmc +1 more source
An automated assay platform for the evaluation of antiviral compounds against polioviruses. [PDF]
Rhoden EE, Mainou BA.
europepmc +1 more source
Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame. [PDF]
Badizadegan K, Thompson KM.
europepmc +1 more source
Atomic Force Microscopy of Poliovirus Particles After Inactivation by Chemical Methods and Accelerated Electrons. [PDF]
Kraevsky SV +10 more
europepmc +1 more source
Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment. [PDF]
Liang J, Zhang Q, Li Y, Wang L.
europepmc +1 more source
Evaluating the Effectiveness of External Molecular Proficiency Testing in the Global Polio Laboratory Network, 2021-2022. [PDF]
Gerloff N, Burns CC.
europepmc +1 more source
Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024. [PDF]
Böttcher S +15 more
europepmc +1 more source

